Protagonist Therapeutics, Inc (PTGX) › EPS (Diluted)Protagonist Therapeutics, Inc (PTGX) — EPS (Diluted)Annual figures by period end, from SEC filings.2020-12-31: $-1.922021-12-31: $-2.712022-12-31: $-2.602023-12-31: $-1.392024-12-31: $4.232025-12-31: $-2.05$-2.052020-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$-2.05-148.5%2026-02-25From 2025-01-012024-12-31$4.23—2026-02-25From 2024-01-012023-12-31$-1.39—2026-02-25From 2023-01-012022-12-31$-2.60—2025-02-21From 2022-01-012021-12-31$-2.71—2024-02-27From 2021-01-012020-12-31$-1.92—2023-03-15From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)